Literature DB >> 12444689

Four new bromotryptamine derivatives from the marine bryozoan Flustra foliacea.

Lars Peters1, Gabriele M König, Heinrich Terlau, Anthony D Wright.   

Abstract

Ten brominated alkaloids, 6-bromo-2-(1,1-dimethyl-2-propenyl)-1H-indole-3-carbaldehyde (1), N-(2-[6-bromo-2-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl]ethyl)-N-methylmethanesulfonamide (2), deformylflustrabromine (3), flustrabromine (4), (3aR,8aS)-6-bromo-3a-[(2E)-3,7-dimethyl-2,6-octadienyl]-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]-indol-7-ol (5), flustramine C (6), dihydroflustramine C (7), flustramine A (8), flustramine D (9), and flustraminol A (10), and the diterpene 4,6-bis(4-methylpent-3-en-1-yl)-6-methylcyclohexa-1,3-diene-carbaldehyde (11) were isolated from the dichloromethane extract of the North Sea bryozoan Flustra foliacea. Of the 10, four (1, 2, 3, and 5) represent new natural products. The structures of all isolates were elucidated by interpretation of their spectroscopic data (NMR, MS, UV, and IR). For compound 4 complete (13)C NMR data are reported for the first time. Compounds 3 and 6-8 were tested on voltage-activated potassium and sodium channels. Flustramine A (8) shows an unspecific blocking activity on Kv1.4 potassium-mediated currents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444689     DOI: 10.1021/np0105984

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  21 in total

1.  Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor.

Authors:  Ayman K Hamouda; Ze-Jun Wang; Deirdre S Stewart; Atul D Jain; Richard A Glennon; Jonathan B Cohen
Journal:  Mol Pharmacol       Date:  2015-04-13       Impact factor: 4.436

2.  Development of the Regiodivergent Asymmetric Prenylation of 3-Substituted Oxindoles.

Authors:  Barry M Trost; Walter H Chan; Sushant Malhotra
Journal:  Chemistry       Date:  2017-03-06       Impact factor: 5.236

Review 3.  Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery.

Authors:  Xiang Rong Tian; Hai Feng Tang; Xiao Lin Tian; Jia Jun Hu; Li Li Huang; Kirk R Gustafson
Journal:  Future Med Chem       Date:  2018-05-23       Impact factor: 3.808

4.  Biochemical characterization of indole prenyltransferases: filling the last gap of prenylation positions by a 5-dimethylallyltryptophan synthase from Aspergillus clavatus.

Authors:  Xia Yu; Yan Liu; Xiulan Xie; Xiao-Dong Zheng; Shu-Ming Li
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

Review 5.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

6.  Secondary metabolites of Flustra foliacea and their influence on bacteria.

Authors:  Lars Peters; Gabriele M König; Anthony D Wright; Rüdiger Pukall; Erko Stackebrandt; Leo Eberl; Kathrin Riedel
Journal:  Appl Environ Microbiol       Date:  2003-06       Impact factor: 4.792

7.  Variation of brominated indoles and terpenoids within single and different colonies of the marine bryozoan Flustra foliacea.

Authors:  Lars Peters; Anthony D Wright; Anja Krick; Gabriele M König
Journal:  J Chem Ecol       Date:  2004-06       Impact factor: 2.626

8.  Enantioselective organocatalytic construction of pyrroloindolines by a cascade addition-cyclization strategy: synthesis of (-)-flustramine B.

Authors:  Joel F Austin; Sung-Gon Kim; Christopher J Sinz; Wen-Jing Xiao; David W C MacMillan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

9.  Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Male Mice.

Authors:  Ayman K Hamouda; Asti Jackson; Deniz Bagdas; M Imad Damaj
Journal:  Nicotine Tob Res       Date:  2018-06-07       Impact factor: 4.244

Review 10.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.